United States: Food, Drugs, Healthcare, Life Sciences

South Dakota Gov. Larry Rhoden has signed a bill that will impose a moratorium on cell-cultured protein in the state from July 1, 2026, to June 30, 2031.

The CMS aims to expand digital health technology usage among Medicare beneficiaries and providers under its new ACCESS Model, where payment is tied to beneficiaries achieving measurable clinical outcomes.

In this episode, Gabriel Scott, Mark Ogunsusi, and Amanda Smith take a focused look at the 340B Drug Pricing Program, with particular attention to recent developments related to proposals for a 340B rebate model.

On March 23, 2026, Bio-Thera Solutions announced an expansion of its existing partnership with Intas Pharmaceuticals for BAT2506, its golimumab biosimilar...

In 2025, Texas passed Senate Bill 25, which includes a labeling mandate for food products. Section 9 of the Bill adds language to the Texas Health and Safety Code that would require food manufacturers to put conspicuous warning labels on any food product sold in the State that contains any of 44 listed ingredients (subject to some exceptions).

On March 20, 2026, the Food and Drug Administration (FDA) announced the agency will hold a public hearing on the Commissioner’s National Priority Voucher (CNPV) Pilot Program, with a Federal Register notice soliciting public comment and scheduling a public hearing for June 12, 2026.

The Federal Trade Commission (FTC) and the Department of Justice’s Antitrust Division (DOJ, and together with the FTC, the Agencies)...

As healthcare providers and institutions explore ways in which artificial intelligence (AI) can address persistent operational...

On February 27, 2026, the Centers for Medicare and Medicaid Services (CMS) announced a six-month nationwide enrollment moratorium prohibiting initial Medicare enrollment for seven types of durable medical equipment...